Pulmatrix Inc
(NASDAQ : PULM)

( )
PULM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Loading PULM News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.80%71.920.9%$761.22m
AMGNAmgen Inc.
1.89%174.071.1%$710.46m
CELGCelgene Corporation
2.58%134.231.1%$663.95m
REGNRegeneron Pharmaceuticals, Inc.
2.21%513.192.7%$597.95m
BIIBBiogen Inc.
1.25%274.641.2%$489.88m
ALXNAlexion Pharmaceuticals, Inc.
3.03%125.811.9%$457.51m
VRTXVertex Pharmaceuticals Incorporated
1.46%131.111.9%$269.73m
INCYIncyte Corporation
3.09%134.332.6%$260.56m
CLVSClovis Oncology, Inc.
4.00%93.5618.0%$251.37m
TSROTESARO, Inc.
2.26%144.2214.7%$245.39m
BLUEBluebird Bio, Inc.
2.06%109.1019.3%$170.10m
ILMNIllumina, Inc.
2.63%181.003.5%$152.76m
KITEKite Pharma, Inc.
4.92%102.8716.1%$146.12m
EXASExact Sciences Corporation
7.36%36.6026.3%$137.06m
BMRNBioMarin Pharmaceutical Inc.
3.35%92.634.4%$124.75m

Company Profile

Pulmatrix, Inc. is a clinical stage biotechnology company, which is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. It designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Edwards, Mark Gabrielson, Alexander Klibanov, and Robert Langer in 2013 and is headquartered in Lexington, MA.